Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.063 | 0.7 |
mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.7 |
mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.7 |